Colonic epithelial physiology is altered in response to the bacterial superantigen Yersinia pseudotuberculosis mitogen

Journal of Infectious Diseases

Volumn 180, Issue 5, 1999, Pages 1590-1596

  Donnelly, G A E ^a   Lu, J ^a   Takeda, T ^b   McKay, D M ^a,c  

^a MCMASTER UNIVERSITY   (Canada)

^b NATIONAL RESEARCH INSTITUTE FOR CHILD HEALTH AND DEVELOPMENT   (Japan)

^c MCMASTER UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC AMP; FORSKOLIN; GAMMA INTERFERON; MITOGENIC AGENT; PIROXICAM; SUPERANTIGEN; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL FUNCTION; COCULTURE; COLON; CONTROLLED STUDY; ENTERITIS; IMMUNE RESPONSE; ION TRANSPORT; MALE; MEMBRANE PERMEABILITY; MONONUCLEAR CELL; MOUSE; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; YERSINIA PSEUDOTUBERCULOSIS;

ANIMALS; BACTERIAL PROTEINS; CELL MEMBRANE PERMEABILITY; CELLS, CULTURED; COCULTURE TECHNIQUES; COLON; CULTURE MEDIA, CONDITIONED; CYTOKINES; FORSKOLIN; HUMANS; INTESTINAL MUCOSA; ION TRANSPORT; LEUKOCYTES, MONONUCLEAR; LYMPHOCYTE ACTIVATION; MALE; MICE; MICE, INBRED BALB C; MITOGENS; SUPERANTIGENS; YERSINIA PSEUDOTUBERCULOSIS;

EID: 0032705058     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/315075     Document Type: Article

References (38)

1. 1. Abe J, Onimaru M, Matsumoto S, et al. Clinical role for a superantigen in Yersinia pseudotuberculosis infection. J Clin Invest 1997;99:1823-30.
2. 2. Blackman MA, Woodland DL. In vivo effects of superantigens. Life Sci 1995;57:1717-35.
3. 3. Abe J, Takeda T, Watanabe Y, et al. Evidence for superantigen production by Yersinia pseudotuberculosis. J Immunol 1993;151:4183-8.
4. 4. Uchiyama T, Miyoshi-Akiyama T, Kato H, Fujimaki W, Imanishi K, Yan XJ. Superantigenic properties of a novel mitogenic substance produced by Yersinia pseudotuberculosis isolated from patients manifesting acute and systemic symptoms. J Immunol 1993;151:4407-13.
5. 5. Schiffenbauer J, Soos J, Johnson H. The possible role of bacterial superantigens in the pathogenesis of autoimmune disorders. Immunol Today 1998;19:117-21.
6. 6. Kay RA. The potential role of superantigens in inflammatory bowel disease. Clin Exp Immunol 1995;100:4-6.
7. 7. Ueshiba H, Kato H, Miyoshi-Akiyama T, et al. Analysis of the superantigen-producing ability of Yersinia pseudotuberculosis strains of various serotypes isolated from patients with systemic or gastroenteric infections, wildlife animals and natural environments. Zentralbl Bakteriol 1998;288:277-91.
8. 8. Yoshino K, Takao T, Ishibashi M, Samejima Y, Shimonishi Y, Takeda T. Identification of the functional region of the superantigen Yersinia pseudotuberculosis derived mitogen responsible for induction of lymphocyte proliferation by using synthetic peptides. FEBS Lett 1996;390:196-8.
9. 9. Lu J, Philpott DJ, Saunders PR, Perdue MH, Yang PC, McKay DM. Epithelial ion transport and barrier abnormalities evoked by superantigen-activated immune cells are inhibited by IL-10, but not IL-4. J Pharm Exp Ther 1998;287:128-36.
10. 2. J Immunol 1997;159:2382-90.
11. 11. Barrett KE. Positive and negative regulation of chloride secretion in T84 cells. Am J Physiol 1993;265:C59-68.
12. + T cells mediate superantigen-induced abnormalities in murine jejunal ion transport. Am J Physiol 1998;275: G29-38.
13. 13. Johnson HM, Russel JK, Pontzer CH. Staphylococcal enterotoxin superantigens. Proc Soc Exp Biol Med 1991;198:765-71.
14. 1 J Immunol 1994;153:5730-9.
15. 15. Snijdewint FGM, Kalinski P, Wierenga EA, Bos JD, Kapsenberg ML. Prostaglandin E, differentially modulates cytokine secretion profiles of human T helper lymphocytes. J Immunol 1993;150:5321-9.
16. 16. van Prohaska J. Role of staphylococcal enterotoxin in the induction of experimental ileitis. Ann Surg 1963;158:492-7.
17. 17. Kent TH. Staphylococcal enterotoxin gastroenteritis in rhesus monkeys. Am J Pathol 1965;48:387-407.
18. 18. Perdue MH, McKay DM. Integrative immunophysiology in the intestinal mucosa. Am J Physiol 1994;267:G151-65.
19. 19. Konishi N, Baba F, Abe J, et al. A case of Kawasaki disease with coronary artery ancurysms documenting Yersinia pseudotuberculosis infection. Acta Paediatr 1997;86:661-4.
20. 20. Delchier J, Constantini CD, Soule JC. Presence of anti Yersinia pseudotuberculosis agglutinins during a flare-up of ileal Crohn's disease. Apropos of 3 cases. Gastroenterol Clin Biol 1983;7:580-4.
21. 21. Miyoshi-Akiyama T, Fujimaki W, Yan XJ, et al. Identification of murine T cells reactive with the bacterial superantigen Yersinia pseudotuberculosis derived mitogen (YPM) and factors involved in YPM-induced toxicity in mice. Microbiol Immunol 1997;41:345-52.
22. 22. McKay DM, Baird AW. Cytokine regulation of epithelial permeability and ion transport. Gut 1999;44:283-9.
23. 23. Miethke T, Wahl C, Heeg K, Echtenacher B, Krammer PH, Wagner H. T cell mediated lethal shock triggered in mice by the superantigen staphylococcal enterotoxin B: critical role of tumor necrosis factor. J Exp Med 1992;175:91-8.
24. 24. Kumar GS, Das UN. Effect of prostaglandins and their precursors on the proliferation of human lymphocytes and their secretion of tumor necrosis factor and various cytokines. Prostaglandins Leukot Essent Fatty Acids 1994;50:331-4.
25. 2. Am J. Physiol 1996;271:G667-74.
26. 26. Kandil HM, Berschneider HM, Argenzio RA. Tumor necrosis factor α changes porcine intestinal ion transport through a paracrine mechanism involving prostaglandins. Gut 1994;35:934-40.
27. 2 stimulated release and metabolism of arachidonic acid in cultured intestinal epithelial cells (INT 407). Scand J Gastroenterol 1993;28:323-30.
28. 28. Zushi S, Shinomura Y, Kiyohara T, et al. Role of prostaglandins in intestinal epithelial restitution stimulated by growth factors. Am J Physiol 1996; 270:G757-62.
29. 29. Cohn SM, Scholoemann S, Tessner T, Stenson WF. Crypt stem cell survival in mouse intestinal epithelium is regulated by prostaglandins synthesized through cyclooxygenase-1. J Clin Invest 1997;99:1367-79.
30. 2 have a synergistic role in rescuing epithelial barrier function in porcine ileum. J Clin Invest 1997;100:1928-33.
31. 31. Curtis GH, MacNaughton WK, Gall DG. Effect of cyclooxygenase inhibition on macromolecular transport in rat gastric mucosa. Am J Physiol 1993; 265:G1135-40.
32. 32. Elmhurst JL, Betti PA, Rangachari PK. Intestinal effects of isoprostanes: evidence for the involvement of prostanoid EP and TP receptors. J Pharm Exp Ther 1997;282:1198-205.
33. 33. Kliewer SA, Lenhard JM, Willson TM, Patel I, Morris DC, Lehmann JM. A prostaglandin J2 metabolite binds peroxisome proliferation activated receptor-γ and promotes adipocyte differentiation. Cell 1995;83:813-9.
34. 34. Di Paolo MC, Merrett MN, Crotty B, Jewell DP. 5-aminosalicylic acid inhibits the impaired epithelial barrier function induced by gamma interferon. Gut 1996;38:115-9.
35. 35. MacNaughton WK, Lowe SS, Cushing K. Role of nitric oxide in inflammation-induced suppression of secretion in a mouse model of acute colitis. Am J Physiol 1998;275:G1353-60.
36. 36. Kachur JF, Keshavarzian A, Sundaresan R, et al. Colitis reduces short-circuit current response to inflammatory mediators in rat colonic mucosa. Inflammation 1995;19:245-59.
37. 2 in colonic epithelial cells in colitis. Eur J Immunol 1993;238:387-90.
38. 38. Nagaki M, Muto Y, Ohnishi H, et al. Hepatic injury and lethal shock in galactosamine-sensitized mice induced by the superantigen staphylococcal enterotoxin B. Gastroenterology 1994;106:450-8.